Express Scripts says company 'well positioned for growth' The company said it is "very well positioned for growth." Says pharmacy is "right place to be today." Comments made at the JP Morgan Healthcare Conference.
Anthem added to Focus List at Citi Citi analyst Ralph Giacobbe added Anthem (ANTM) to his firm's Focus List. As Anthem and Express Scripts (ESRX) continue to negotiate their pharmacy benefits manager contract, the analyst sees UnitedHealth (UNH) as a potential alternative for Anthem. Regardless of the outcome, Anthem is in the "driver's seat for significant savings/upside," which is not reflected in the stock. Giacobbe tells investors in a research note. He keeps a Buy rating on the name with a $172 price target.